Ropinirole suppresses LPS-induced periodontal inflammation by inhibiting the NAT10 in an ac4C-dependent manner
Abstract Background Periodontitis is a chronic osteolytic inflammatory disease, where anti-inflammatory intervention is critical for restricting periodontal damage and regenerating alveolar bone. Ropinirole, a dopamine D2 receptor agonist, has previously shown therapeutic potential for periodontitis...
Saved in:
Main Authors: | Haiqing Liao (Author), Huabing Ma (Author), Hongying Meng (Author), Na Kang (Author), Lufei Wang (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
LPS-Induced Inflammation Affects Midazolam Clearance in Juvenile Mice in an Age-Dependent Manner
by: Zheng Y, et al.
Published: (2021) -
Mechanisms of NAT10 as ac4C writer in diseases
by: Lihua Xie, et al.
Published: (2023) -
Nanotechnology-based drug delivery of ropinirole for Parkinson's disease
by: Emilia Barcia, et al.
Published: (2017) -
Development and optimization of Ropinirole loaded self-nanoemulsifying tablets
by: Krunal Detholia, et al.
Published: (2023) -
RNPS1 stabilizes NAT10 protein to facilitate translation in cancer via tRNA ac4C modification
by: Xiaochen Wang, et al.
Published: (2024)